TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22760386

Group type: EXPERIMENTAL
Intervention: 3M DuraPrep Surgical Solution Patient Preoperative Skin Preparation
Number of subjects: 22

Group type: COMPARATOR
Intervention: ChloraPrep with Tint (Scrub Teal) Patient Preoperative Skin Preparation
Number of subjects: 22
Study: 20975106

Group type: EXPERIMENTAL
Intervention: Silica-based mineral antioxidant complex (MAC) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rice flour (placebo)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water only (baseline)
Number of subjects: 0
Study: 17914062

Group type: EXPERIMENTAL
Intervention: MK-0974 300 mg
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: MK-0974 400 mg
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: MK-0974 600 mg
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 15365138

Group type: EXPERIMENTAL
Intervention: Topiramate (n = 214)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo (n = 109)
Number of subjects: 323
Study: 11302269

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9385350

Group type: EXPERIMENTAL
Intervention: Low-dose cladribine (2‐CdA) at a dosage of 0.05 mg/kg subcutaneously weekly for 8 weeks
Number of subjects: 5
Study: 8174421

Group type: EXPERIMENTAL
Intervention: Indomethacin (N = 15)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Oxicam (N = 36)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (N = 26)
Number of subjects: 77
Study: 2975949

Group type: EXPERIMENTAL
Intervention: Warfarin (n = 56)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (n = 54)
Number of subjects: 110
Study: 29735215

Group type: EXPERIMENTAL
Intervention: MMF dispersible tablets (MMFdt)
Number of subjects: 40

Group type: COMPARATOR
Intervention: MMF capsules (MMFc)
Number of subjects: 40
Study: 26390408

Group type: EXPERIMENTAL
Intervention: Modified user guide
Number of subjects: 89

Group type: COMPARATOR
Intervention: Original user guide
Number of subjects: 89
Study: 24740408

Group type: EXPERIMENTAL
Intervention: Portex Group (bevel facing left)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Parker Group (bevel facing posteriorly)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stylet‐Portex Group (stylet bent at 60° with Portex tube)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stylet‐Parker Group (stylet bent at 60° with Parker tube)
Number of subjects: 200
Study: 22278741

Group type: EXPERIMENTAL
Intervention: simvastatin alone (40 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin combined therapy (10/20 or 10/40 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All patients (combined group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/40 mg/day
Number of subjects: 30
Study: 20735823

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics (PE) programme
Number of subjects: 19
Study: 17635889

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 1537) received a telephone counseling program with cooking classes and newsletters promoting dietary targets of 5 vegetable servings, 3 fruit servings, 30 g of fiber, and 15%-20% energy from fat.
Number of subjects: 3088

Group type: COMPARATOR
Intervention: Comparison group (n = 1551) received print materials describing the '5-A-Day' dietary guidelines.
Number of subjects: 3088
Study: 16214920

Group type: EXPERIMENTAL
Intervention: Intensive dietary intervention
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 11961679

Group type: EXPERIMENTAL
Intervention: Intervention group (n=1072)
Number of subjects: 1552

Group type: COMPARATOR
Intervention: Control group (n=480)
Number of subjects: 1552
Study: 18370541

Group type: EXPERIMENTAL
Intervention: valsartan 80mg + HCTZ 12.5mg
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: valsartan 80mg + HCTZ 25mg
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: valsartan 160mg
Number of subjects: 708

Group type: COMPARATOR
Intervention: valsartan 80mg
Number of subjects: 708
Study: 8127206

Group type: EXPERIMENTAL
Intervention: Low intensity near-infrared laser radiation (830 nm; 1.5 J/cm2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low intensity near-infrared laser radiation (830 nm; 3.0 J/cm2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low intensity near-infrared laser radiation (830 nm; 6.0 J/cm2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low intensity near-infrared laser radiation (830 nm; 9.0 J/cm2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low intensity near-infrared laser radiation (830 nm; 12 J/cm2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 80
Study: 2511698

Group type: EXPERIMENTAL
Intervention: 15 mg nitroglycerine patch (70% drug release during the first 12 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 15 mg nitroglycerine patch (subchronic application)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 12
Study: 1103709

Group type: EXPERIMENTAL
Intervention: Chlormezanone
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Orphenadrine
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Orphenadrine/Paracetamol
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 31368382

Group type: EXPERIMENTAL
Intervention: ICBTi (Internet-based cognitive behavioral therapy for insomnia)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Web-based patient education
Number of subjects: 178
Study: 28606961

Group type: EXPERIMENTAL
Intervention: Disease activity-guided dose reduction (DR)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 172
Study: 26850061

Group type: EXPERIMENTAL
Intervention: Feedback intervention using text messaging (SMS)
Number of subjects: 1488

Group type: EXPERIMENTAL
Intervention: Feedback intervention using text messaging (SMS) + 45-min nutrition education session
Number of subjects: 1488

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1488
Study: 24255998

Group type: EXPERIMENTAL
Intervention: Additional individual, disorder-specific, cognitive-behavioral psychotherapy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Medication and medical management only (Control)
Number of subjects: 109
Study: 21879261

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with cisplatin and 5-fluorouracil (group 1)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with cisplatin and 5-fluorouracil (group 2)
Number of subjects: 330
Study: 19597976

Group type: COMPARATOR
Intervention: Placebo acupuncture treatment
Number of subjects: 27
Study: 17502802

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) delivered to the left dorsolateral prefrontal cortex at a frequency of 10 Hz in 5-second trains at 110% of the estimated prefrontal cortex threshold
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 68
Study: 14756912

Group type: EXPERIMENTAL
Intervention: Lingzhi supplementation (1.44 g Lingzhi/d; equivalent to 13.2 g fresh mushroom/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11668420

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparins with decreasing molecular weights
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparins with longer chains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparins with higher molecular weight
Number of subjects: 0
Study: 10434164

Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 140
Study: 7792309

Group type: EXPERIMENTAL
Intervention: Raloxifene (200 mg daily for 10 days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg twice a day for 10 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (for 10 days)
Number of subjects: 17
Study: 2193306

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 303

Group type: COMPARATOR
Intervention: Usual diet (Control)
Number of subjects: 303
Study: 852810

Group type: EXPERIMENTAL
Intervention: Betamethasone phosphate/acetate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Betamethasone phosphate/dipropionate
Number of subjects: 0
Study: 31607205

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily for 18 months
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 27755256

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Nonattenders (Control)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Age >75 years (Predictor for non-attendance)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Ethnic minorities (Predictor for completion)
Number of subjects: 250
Study: 25539895

Group type: EXPERIMENTAL
Intervention: Indapamide 1.5 mg daily
Number of subjects: 565

Group type: COMPARATOR
Intervention: Enalapril 10 mg daily
Number of subjects: 565
Study: 23590998

Group type: EXPERIMENTAL
Intervention: Female group (F): only female participants
Number of subjects: 251

Group type: COMPARATOR
Intervention: Standard group (S): male and female participants
Number of subjects: 251
Study: 21994128

Group type: EXPERIMENTAL
Intervention: Intraocular fluocinolone acetonide implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard systemic therapy
Number of subjects: 0
Study: 19292785

Group type: EXPERIMENTAL
Intervention: PUVA maintenance treatment (irradiation twice weekly and then once weekly for 4 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No maintenance treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: PUVA maintenance treatment
Number of subjects: 34
Study: 17716323

Group type: EXPERIMENTAL
Intervention: Synera patch (lidocaine 70 mg and tetracaine 70 mg, 20-minute treatment)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (20-minute treatment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Synera patch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15244013

Group type: EXPERIMENTAL
Intervention: Cetraxate plus clarithromycin and amoxicillin (CCA group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pantoprazole plus clarithromycin and amoxicillin (PCA group)
Number of subjects: 58
Study: 11398691

Group type: EXPERIMENTAL
Intervention: Gastrically placed feeding tube
Number of subjects: 54

Group type: COMPARATOR
Intervention: Transpylorically placed feeding tube
Number of subjects: 54
Study: 9512152

Group type: EXPERIMENTAL
Intervention: Adjunctive subconjunctival mitomycin C
Number of subjects: 197

Group type: COMPARATOR
Intervention: No adjunctive mitomycin C
Number of subjects: 197
Study: 1729932

Group type: EXPERIMENTAL
Intervention: 3 mg/kg ketamine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6 mg/kg ketamine
Number of subjects: 45

Group type: COMPARATOR
Intervention: No ketamine (control)
Number of subjects: 45
Study: 3838120

Group type: EXPERIMENTAL
Intervention: Piloplex (three concentrations)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vehicle of the drug
Number of subjects: 12
Study: 31854356

Group type: EXPERIMENTAL
Intervention: MIS seven implants
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Alphadent active implants
Number of subjects: 17
Study: 30189821

Group type: EXPERIMENTAL
Intervention: Ambu® AuraGain™ laryngeal mask (AG)
Number of subjects: 116

Group type: COMPARATOR
Intervention: LMA® Fastrach™ (FT)
Number of subjects: 116
Study: 26249765

Group type: EXPERIMENTAL
Intervention: Rabeprazole sterile powder for injection (RSPI) 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rabeprazole sterile powder for injection (RSPI) 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rabeprazole sterile powder for injection (RSPI) 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rabeprazole sterile powder for injection (RSPI) multiple doses 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pariet® 20 mg (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of RSPI and Pariet®
Number of subjects: 0
Study: 22956839

Group type: EXPERIMENTAL
Intervention: Neural activity following stimulus encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neural activity preceding the stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recent choice history
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diffusion model fitted to choice probabilities and response time distributions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prestimulus brain activity
Number of subjects: 0
Study: 19454840

Group type: EXPERIMENTAL
Intervention: SFC (50/100 microg, 13 patients)
Number of subjects: 27

Group type: COMPARATOR
Intervention: FP (100 microg, 14 patients)
Number of subjects: 27
Study: 17393309

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 115

Group type: COMPARATOR
Intervention: Therapeutic substitution program (lansoprazole-rabeprazole)
Number of subjects: 115
Study: 15380897

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum 299v (ProViva), median volume 3250 ml, median duration 9 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no probiotic)
Number of subjects: 22
Study: 11252881

Group type: EXPERIMENTAL
Intervention: 30-minute music intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 140
Study: 9673862

Group type: EXPERIMENTAL
Intervention: Calcitonin and etidronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D metabolites (calcitriol or 1 alpha‐calcidol) and estrogens
Number of subjects: 0
Study: 8540748

Group type: EXPERIMENTAL
Intervention: Ascoxal (ascorbic acid-containing solution), applied topically 3 times for 2 min on the first day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo, applied topically 3 times for 2 min on the first day
Number of subjects: 32
Study: 2551988

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg b.i.d. + Indomethacin 50 mg b.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.i.d. + Indomethacin 50 mg b.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg b.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg b.i.d. and Enalapril 20 mg o.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg b.i.d.
Number of subjects: 8
Study: 749190

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy added to radical mastectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination chemo- or chemo-hormono-therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local therapy alone (surgery with or without postoperative radiotherapy)
Number of subjects: 0
Study: 31889621

Group type: EXPERIMENTAL
Intervention: More equitable gender attitudes
Number of subjects: 866

Group type: EXPERIMENTAL
Intervention: Witnessing peers engaged in abusive behaviors (witnessed 3 or more behaviors)
Number of subjects: 866
Study: 31175747

Group type: EXPERIMENTAL
Intervention: Fitness technologies program
Number of subjects: 600

Group type: COMPARATOR
Intervention: Traditional educational system (Control)
Number of subjects: 600
Study: 28816951

Group type: EXPERIMENTAL
Intervention: Therapeutic care (TC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 48
Study: 26111922

Group type: EXPERIMENTAL
Intervention: Kaatsu training (low-load exercise with externally-applied compression) for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Center-based, moderate-load resistance training for 3 months
Number of subjects: 0
Study: 23233269

Group type: EXPERIMENTAL
Intervention: Oxytocin intranasal spray (20 IU twice a day for the first week, then 40 IU twice a day for the following 7 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oxytocin intranasal spray
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo intranasal spray (normal saline)
Number of subjects: 40
Study: 21644085

Group type: EXPERIMENTAL
Intervention: Kendrick extrication device (KED)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Long spinal backboard with straps
Number of subjects: 60
Study: 18355812

Group type: EXPERIMENTAL
Intervention: Endometrial biopsy on days 11‐13 and 21‐24 of the preceding cycle
Number of subjects: 2

Group type: COMPARATOR
Intervention: Endometrial biopsy on days 20‐21 of the spontaneous menstrual cycle
Number of subjects: 2
Study: 17371175

Group type: EXPERIMENTAL
Intervention: Computerized decision support system (CDSS)
Number of subjects: 51
Study: 15056124

Group type: EXPERIMENTAL
Intervention: HCA-SX 4667 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of HCA-SX 4667 mg, NBC 4 mg, and GSE 400 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11763951

Group type: EXPERIMENTAL
Intervention: 1.25 g dentifrice containing 0.3% triclosan (3.75 mg triclosan dose) - single-dose phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three times daily brushing with 1.25 g dentifrice containing 0.3% triclosan - multiple-dose phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Twice daily brushing with 1 gm of dentifrice containing 0.2% triclosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 9574192

Group type: EXPERIMENTAL
Intervention: Antibiotic carrier (group 1)
Number of subjects: 324

Group type: COMPARATOR
Intervention: No antibiotic carrier (group 2)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Secondary wound healing with hydrocolloidal moist wound dressings
Number of subjects: 324
Study: 7840418

Group type: EXPERIMENTAL
Intervention: Ketamine 1.3 mg/kg bolus + 4 mg/kg/h continuous for 15 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min + physostigmine 0.012 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min + saline placebo
Number of subjects: 12
Study: 3043371

Group type: EXPERIMENTAL
Intervention: Relaxation Response training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo exercise
Number of subjects: 24
Study: 31188681

Group type: EXPERIMENTAL
Intervention: Hyperoxic preconditioning (pure oxygen for 5 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non hyperoxic preconditioning (chamber air for 5 minutes)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hyperoxic preconditioning
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non hyperoxic preconditioning
Number of subjects: 17
Study: 29050384

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (real)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 28
Study: 26235659

Group type: EXPERIMENTAL
Intervention: Self-help booklets (n=703)
Number of subjects: 1407

Group type: COMPARATOR
Intervention: Control leaflet (n=704)
Number of subjects: 1407
Study: 23939394

Group type: EXPERIMENTAL
Intervention: CPPED1 knockdown with small interfering RNA
Number of subjects: 0
Study: 21749984

Group type: EXPERIMENTAL
Intervention: VBN-assisted EBUS (VBNA)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Non-VBN-assisted EBUS (NVBNA)
Number of subjects: 199

Group type: COMPARATOR
Intervention: NVBNA
Number of subjects: 199
Study: 19491872

Group type: EXPERIMENTAL
Intervention: Laparoscopic anti-reflux surgery (LARS)
Number of subjects: 1036
Study: 16882375

Group type: EXPERIMENTAL
Intervention: Learner-centred approach focusing on actual needs
Number of subjects: 100

Group type: COMPARATOR
Intervention: Current educational activities
Number of subjects: 100
Study: 15333799

Group type: EXPERIMENTAL
Intervention: Interactive protocol (n = 20)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard protocol (n = 19)
Number of subjects: 45
Study: 10884455

Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 49

Group type: COMPARATOR
Intervention: Patching
Number of subjects: 49
Study: 9356091

Group type: EXPERIMENTAL
Intervention: verapamil 0.1 mg/kg I.V. plus saline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: lidocaine 1 mg/kg I.V. plus saline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: verapamil 0.1 mg/kg I.V. plus lidocaine 1 mg/kg I.V.
Number of subjects: 100

Group type: COMPARATOR
Intervention: saline plus saline (control)
Number of subjects: 100
Study: 8108605

Group type: EXPERIMENTAL
Intervention: Mental stimulation (reading, performing mental arithmetic, playing a hand-held 'Nintendo' game)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Resting
Number of subjects: 5

Group type: COMPARATOR
Intervention: Mental stimulation
Number of subjects: 5
Study: 3954370

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (2 mg/kg x 4: H)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate-dose metoclopramide (1 mg/kg x 4: M)
Number of subjects: 0
Study: 28434131

Group type: EXPERIMENTAL
Intervention: Integrated instruction (conceptual Why and procedural How knowledge)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unintegrated instruction (procedural How instruction only)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Integrated instruction
Number of subjects: 30
Study: 27526655

Group type: EXPERIMENTAL
Intervention: Suction drainage at -20 cm H2O
Number of subjects: 254

Group type: COMPARATOR
Intervention: Nonsuction drainage
Number of subjects: 254
Study: 24808482

Group type: EXPERIMENTAL
Intervention: Weekly context-appropriate child-centered counseling (CCC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Improved corn-soy blend (CSB++)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Locally produced ready-to-use supplementary food (RUSF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CCC
Number of subjects: 18

Group type: COMPARATOR
Intervention: CSB++ and RUSF
Number of subjects: 18